Patent · US Active

CRISPR/Cas transcriptional modulation

US11254933B2 · kind B2 · utility

3Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2015
Grant dateFeb 22, 2022
Priority date
Expiry dateJul 14, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6897
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods, compositions, and kits are provided for CRISPR/Cas mediated transcriptional modulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.